This workshop looked at ways to improve both disease and vector surveillance. Vaccine, vector, laboratory, epidemiology and public health specialists reviewed the current dengue control situation and laboratory diagnostic techniques. The participants discussed areas for future development, such as more robust surveillance systems and new intervention tools, as well as the idea of introducing surveillance to areas that do not currently have systems in place, with a focus on Africa.
Experts at the workshop discussed potential items for the operational research agenda in the fields of vector control, surveillance and diagnostics. They agreed on a general need to design key messages and initiatives for targeted audiences. In the context of the introduction of a dengue vaccine and the emergence of new tools, they emphasized the importance of developing advocacy and communication roadmaps.
Experts at the workshop discussed potential items for the operational research agenda in the fields of vector control, surveillance and diagnostics. They agreed on a general need to design key messages and initiatives for targeted audiences. In the context of the introduction of a dengue vaccine and the emergence of new tools, they emphasized the importance of developing advocacy and communication roadmaps.
Several recommendations were developed in support of a global strategy for dengue control:
PDC is ready to engage with several partners to improve integration of laboratory and disease surveillance, in particular focusing on more sensitive and rapid diagnostic tests. Another key factor to improve dengue surveillance is enhanced data and information sharing.
| 08h30 – 14h30
|
Topic 1: Changes in dengue surveillance in the context of the introduction of new tools for control |
| Plenary: State of the art disease surveillance (H. Margolis) | |
| Plenary: State of the art vector surveillance (S. Ritchie) | |
| Plenary: Key issues that could affect surveillance results for an integrated disease and vector surveillance system in a country where an integrated control program has been initiated. (S. Ritchie and G. Thiry) | |
| Workshop A: Disease surveillance in the context of vaccine introduction (D. Gubler) | |
| Workshop B: How to perform integrated surveillance (H. Gomez) | |
| Discussion of Topic 1 (H. Gomez) | |
| 14h30 – 18h00
|
Topic 2: Laboratory techniques and surveillance |
| Plenary: State of the art currently available laboratory methods and new approaches for diagnosis and surveillance (E. Harris) | |
| Workshop C: How do we currently use available technology to support disease and vector surveillance? (M. Guzman) | |
| Workshop D: New and innovative technology (E. Harris) | |
| Discussion of Topic 2 (E. Harris) |
| 09h00 – 14h30 | Topic 3: New technologies |
| Plenary: How new technologies may improve surveillance in areas with and without capacity (M. Smolinski) | |
| Plenary: New technologies for surveillance mapping (T. Scott) | |
| Workshop E: How could social networks help to improve the current surveillance of dengue? (M. Smolinski) | |
| Workshop F: Can we use new technologies (such as specific software for cell phones), for surveillance in remote areas? What are the implications in terms of lay public involvement, but also in terms of sensitivity and specificity? (M. Betancourt) | |
| Discussion of Topic 3 (M. Smolinski) | |
| 14h30 – 17h00 | Topic 4: Surveillance in countries that do not have any system in place |
| Plenary: State of the art issues in specific contexts – focus on Africa (H. Margolis) | |
| Workshop G: What methodology/indicators should be put in place in countries where nothing exists? (J. Lim and H. Margolis) | |
| Discussion of Topic 4 (H. Margolis) | |
| 17h00 – 18h00 | Consensus on conclusions from the meeting |
This workshop looked at ways to improve both disease and vector surveillance. Vaccine, vector, laboratory, epidemiology and public health specialists reviewed the current dengue control situation and laboratory diagnostic techniques. The participants discussed areas for future development, such as more robust surveillance systems and new intervention tools, as well as the idea of introducing surveillance to areas that do not currently have systems in place, with a focus on Africa.
Experts at the workshop discussed potential items for the operational research agenda in the fields of vector control, surveillance and diagnostics. They agreed on a general need to design key messages and initiatives for targeted audiences. In the context of the introduction of a dengue vaccine and the emergence of new tools, they emphasized the importance of developing advocacy and communication roadmaps.
Experts at the workshop discussed potential items for the operational research agenda in the fields of vector control, surveillance and diagnostics. They agreed on a general need to design key messages and initiatives for targeted audiences. In the context of the introduction of a dengue vaccine and the emergence of new tools, they emphasized the importance of developing advocacy and communication roadmaps.
Several recommendations were developed in support of a global strategy for dengue control:
PDC is ready to engage with several partners to improve integration of laboratory and disease surveillance, in particular focusing on more sensitive and rapid diagnostic tests. Another key factor to improve dengue surveillance is enhanced data and information sharing.
| 08h30 – 14h30
|
Topic 1: Changes in dengue surveillance in the context of the introduction of new tools for control |
| Plenary: State of the art disease surveillance (H. Margolis) | |
| Plenary: State of the art vector surveillance (S. Ritchie) | |
| Plenary: Key issues that could affect surveillance results for an integrated disease and vector surveillance system in a country where an integrated control program has been initiated. (S. Ritchie and G. Thiry) | |
| Workshop A: Disease surveillance in the context of vaccine introduction (D. Gubler) | |
| Workshop B: How to perform integrated surveillance (H. Gomez) | |
| Discussion of Topic 1 (H. Gomez) | |
| 14h30 – 18h00
|
Topic 2: Laboratory techniques and surveillance |
| Plenary: State of the art currently available laboratory methods and new approaches for diagnosis and surveillance (E. Harris) | |
| Workshop C: How do we currently use available technology to support disease and vector surveillance? (M. Guzman) | |
| Workshop D: New and innovative technology (E. Harris) | |
| Discussion of Topic 2 (E. Harris) |
| 09h00 – 14h30 | Topic 3: New technologies |
| Plenary: How new technologies may improve surveillance in areas with and without capacity (M. Smolinski) | |
| Plenary: New technologies for surveillance mapping (T. Scott) | |
| Workshop E: How could social networks help to improve the current surveillance of dengue? (M. Smolinski) | |
| Workshop F: Can we use new technologies (such as specific software for cell phones), for surveillance in remote areas? What are the implications in terms of lay public involvement, but also in terms of sensitivity and specificity? (M. Betancourt) | |
| Discussion of Topic 3 (M. Smolinski) | |
| 14h30 – 17h00 | Topic 4: Surveillance in countries that do not have any system in place |
| Plenary: State of the art issues in specific contexts – focus on Africa (H. Margolis) | |
| Workshop G: What methodology/indicators should be put in place in countries where nothing exists? (J. Lim and H. Margolis) | |
| Discussion of Topic 4 (H. Margolis) | |
| 17h00 – 18h00 | Consensus on conclusions from the meeting |
